As shown in the propagation assay displayed in Fig. 6, the block of pathological tau release caused by LY379268 was prevented by the mGlu2/3 antagonist LY341495 in both TgP301S and human Alzheimer’s disease synaptosomes (Fig. 7A-H). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.